Jane Street
BLTE icon

Jane Street’s Belite Bio BLTE Stock Holding History

Jane Street’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
65,801
+53,579
+438% +$8.21M ﹤0.01% 2816
2026
Q1 		$1.95M Sell
12,222
-20,096
-62% -$3.38M ﹤0.01% 5147
2025
Q4 		$5.17M Buy
+32,318
New +$3.83M ﹤0.01% 3177

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's BLTE Position: Q2 2026 in Review

Jane Street increased its Belite Bio (BLTE) stake by 438% in Q2 2026, buying an estimated $8.21M and bringing the position to 65,801 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2816.

Jane Street first reported a position in BLTE in Q4 2025 and has held it in 3 quarters since. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Jane Street held 65,801 shares of Belite Bio worth $10.1M as of Q2 2026.
  • Jane Street bought 53,579 Belite Bio shares in Q2 2026, an estimated $8.21M.
  • Belite Bio made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2816 holding.
  • Jane Street first reported a position in Belite Bio in Q4 2025 and has held it in 3 quarters since.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.